Literature DB >> 25582852

The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.

Hiroko Hatano1, Jacqueline Shaw1, Kaitlin Marquardt2, Zhiyong Zhang1, Laurent Gauthier3, Stephanie Chanteux3, Benjamin Rossi3, Demin Li4, Julie Mitchell2, Simon Kollnberger5.   

Abstract

We proposed that the killer cell Ig-like receptor KIR3DL2 binding more strongly to HLA-B27 (B27) β2-microglobulin free H chain (FHC) dimers than other HLA-class I molecules regulates lymphocyte function in arthritis and infection. We compared the function of B27 FHC dimers with other class I H chains and identified contact residues in KIR3DL2. B27 FHC dimers interacted functionally with KIR3DL2 on NK and reporter cells more strongly than did other class I FHCs. Mutagenesis identified key residues in the D0 and other Ig-like domains that were shared and distinct from KIR3DL1 for KIR3DL2 binding to B27 and other class I FHCs. We modeled B27 dimer binding to KIR3DL2 and compared experimental mutagenesis data with computational "hot spot" predictions. Modeling predicts that the stronger binding of B27 dimers to KIR3DL2 is mediated by nonsymmetrical complementary contacts of the D0 and D1 domains with the α1, α2, and α3 domains of both B27 H chains. In contrast, the D2 domain primarily contacts residues in the α2 domain of one B27 H chain. These findings provide novel insights about the molecular basis of KIR3DL2 binding to B27 and other ligands and suggest an important role for KIR3DL2-B27 interactions in controlling the function of NK cells in B27(+) individuals.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25582852      PMCID: PMC4621334          DOI: 10.4049/jimmunol.1402214

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  The detection of NK cell alloreactivity by flow cytometric CD107a assay.

Authors:  Dianne De Santis; Bree Foley; Campbell S Witt; Frank T Christiansen
Journal:  Methods Mol Biol       Date:  2012

2.  Protein structure modeling with MODELLER.

Authors:  Narayanan Eswar; David Eramian; Ben Webb; Min-Yi Shen; Andrej Sali
Journal:  Methods Mol Biol       Date:  2008

3.  HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2013-09-09       Impact factor: 5.422

4.  Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis.

Authors:  Shehzad Z Sheikh; Katsuyoshi Matsuoka; Taku Kobayashi; Fengling Li; Tara Rubinas; Scott E Plevy
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

5.  Association of KIR genotype with susceptibility to HLA-B27-positive ankylosing spondylitis.

Authors:  Sheng Wang; Guixing Li; Rui Ge; Zhenhua Duan; Zhen Zeng; Tianchen Zhang; Jing Gao; Ting Yang; Si Liu; Shanshan Wu; Dazhi Fan; Shengqian Xu; Jianhua Xu; Li Zhang; Zongwen Shuai; Dongqing Ye; Yanfeng Zou; Faming Pan
Journal:  Mod Rheumatol       Date:  2012-06-29       Impact factor: 3.023

6.  Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response.

Authors:  Ingo M Irmler; Mieczyslaw Gajda; Rolf Bräuer
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

Review 7.  KIR-HLA intercourse in HIV disease.

Authors:  Mary Carrington; Maureen P Martin; Jeroen van Bergen
Journal:  Trends Microbiol       Date:  2008-10-29       Impact factor: 17.079

8.  Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.

Authors:  Federico Perosa; Grazia Luccarelli; Marcella Prete; Elvira Favoino; Soldano Ferrone; Franco Dammacco
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

9.  The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.

Authors:  D Pende; R Biassoni; C Cantoni; S Verdiani; M Falco; C di Donato; L Accame; C Bottino; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 10.  The biochemistry and immunology of non-canonical forms of HLA-B27.

Authors:  Jacqueline Shaw; Hiroko Hatano; Simon Kollnberger
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

View more
  6 in total

Review 1.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

Review 2.  HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.

Authors:  Robert Busch; Simon Kollnberger; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

3.  Divide, Conquer, and Sense: CD8+CD28- T Cells in Perspective.

Authors:  Fernando A Arosa; André J Esgalhado; Carolina A Padrão; Elsa M Cardoso
Journal:  Front Immunol       Date:  2017-01-03       Impact factor: 7.561

Review 4.  The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

Authors:  Danillo G Augusto
Journal:  Front Genet       Date:  2016-06-28       Impact factor: 4.599

5.  Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.

Authors:  Anna Ridley; Hiroko Hatano; Isabel Wong-Baeza; Jacqueline Shaw; Katherine K Matthews; Hussein Al-Mossawi; Kristin Ladell; David A Price; Paul Bowness; Simon Kollnberger
Journal:  Arthritis Rheumatol       Date:  2016-04       Impact factor: 10.995

6.  Peptidome analysis of umbilical cord mesenchymal stem cell (hUC-MSC) conditioned medium from preterm and term infants.

Authors:  Yu Wang; Lin Zhang; Yun Wu; Rongping Zhu; Yan Wang; Yan Cao; Wei Long; Chenbo Ji; Huaiyan Wang; Lianghui You
Journal:  Stem Cell Res Ther       Date:  2020-09-23       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.